AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Cariglim M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Caris Labs LLP

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Cariglim M 1mg/500mg Tablet

GlucoDuo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose. Administer GlucoDuo with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat it. Maintain regular meals and carry a rapid-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Inform your doctor of any heart conditions before commencing treatment. Pregnant or lactating individuals require physician consultation prior to use. Regular blood glucose monitoring, along with blood cell and liver function tests as advised by your doctor, is essential.

Primary Ingredients of Cariglim M 1mg/500mg Tablet

No text was provided to rewrite.

Uses of Cariglim M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Cariglim M 1mg/500mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Cariglim M 1mg/500mg Tablet with a meal.

Common Side effects of Cariglim M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Cariglim M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Cariglim M 1mg/500mg Tablet with a meal.

How Cariglim M 1mg/500mg Tablet works:

Cariglim M tablets (1mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Cariglim M 1mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Cariglim M 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Lactation and Cariglim M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with impaired kidney function should exercise caution when using Cariglim M 1mg/500mg tablets, as dosage modification may be necessary. Consult your physician for guidance. The use of Cariglim M 1mg/500mg tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Cariglim M 1mg/500mg tablets cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver disease, initiation with a reduced dosage is typical; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Cariglim M 1mg/500mg Tablet :

Should you forget a Cariglim M 1mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Cariglim M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Cariglim M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Cariglim M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these, discontinue Cariglim M 1mg/500mg and seek immediate medical attention.
Cariglim M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's unsuitable for type 1 diabetes.
Cariglim M 1mg/500mg Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Cariglim M 1mg/500mg tablets can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental Vitamin B12 intake is recommended by some researchers.
Cariglim M 1mg/500mg Tablet can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Cariglim M 1mg/500mg Tablet with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Cariglim M 1mg/500mg Tabl...
53
MRP 65
18% off